Advertisement
  • plos.org
  • create account
  • sign in

PLOS ONE

  • Publish
    • Submissions
      • Getting Started
      • Submission Guidelines
      • Figures
      • Tables
      • Supporting Information
      • LaTeX
      • What We Publish
      • Preprints
      • Revising Your Manuscript
      • Submit Now
      • Calls for Papers
    • Policies
      • Best Practices in Research Reporting
      • Human Subjects Research
      • Animal Research
      • Competing Interests
      • Disclosure of Funding Sources
      • Licenses and Copyright
      • Data Availability
      • Complementary Research
      • Materials and Software Sharing
      • Ethical Publishing Practice
      • Authorship
      • Downloads and Translations
    • Manuscript Review and Publication
      • Criteria for Publication
      • Editorial and Peer Review Process
      • Editor Center
      • Guidelines for Reviewers
      • Accepted Manuscripts
      • Corrections and Retractions
      • Comments

    Submit Your Manuscript

    Discover a faster, simpler path to publishing in a high-quality journal. PLOS ONE promises fair, rigorous peer review, broad scope, and wide readership – a perfect fit for your research every time.

    Learn More Submit Now

  • About
    • Why Publish with PLOS ONE
    • Journal Information
    • Staff Editors
    • Editorial Board
    • Section Editors
    • Advisory Groups
    • Find and Read Articles
    • Publishing Information
    • Publication Fees
    • Press and Media
    • Contact
  • Browse
  • Search
    advanced search
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Peer-reviewed

Research Article

Combination of poly I:C and Pam3CSK4 enhances activation of B cells in vitro and boosts antibody responses to protein vaccines in vivo

  • Genevieve M. Weir ,

    * E-mail: gweir@imvaccine.com

    Affiliations Research & Development, Immunovaccine Inc, Halifax, Nova Scotia, Canada, Department of Microbiology & Immunology, Dalhousie University, Halifax, Nova Scotia, Canada

    ORCID logo http://orcid.org/0000-0002-6285-7187

    ⨯
  • Mohan Karkada,

    Affiliations Research & Development, Immunovaccine Inc, Halifax, Nova Scotia, Canada, Department of Microbiology & Immunology, Dalhousie University, Halifax, Nova Scotia, Canada

    ⨯
  • David Hoskin,

    Affiliations Department of Microbiology & Immunology, Dalhousie University, Halifax, Nova Scotia, Canada, Department of Pathology, Dalhousie University, Halifax, Nova Scotia, Canada

    ⨯
  • Marianne M. Stanford,

    Affiliations Research & Development, Immunovaccine Inc, Halifax, Nova Scotia, Canada, Department of Microbiology & Immunology, Dalhousie University, Halifax, Nova Scotia, Canada

    ⨯
  • Lisa MacDonald,

    Affiliation Research & Development, Immunovaccine Inc, Halifax, Nova Scotia, Canada

    ⨯
  • Marc Mansour,

    Affiliation Research & Development, Immunovaccine Inc, Halifax, Nova Scotia, Canada

    ⨯
  • Robert S. Liwski

    Affiliations Department of Microbiology & Immunology, Dalhousie University, Halifax, Nova Scotia, Canada, Department of Pathology, Dalhousie University, Halifax, Nova Scotia, Canada, Department of Pathology and Laboratory Medicine, Division of Hematopathology, Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia, Canada

    ⨯

Combination of poly I:C and Pam3CSK4 enhances activation of B cells in vitro and boosts antibody responses to protein vaccines in vivo

  • Genevieve M. Weir, 
  • Mohan Karkada, 
  • David Hoskin, 
  • Marianne M. Stanford, 
  • Lisa MacDonald, 
  • Marc Mansour, 
  • Robert S. Liwski
PLOS
x
  • Published: June 29, 2017
  • https://doi.org/10.1371/journal.pone.0180073
  • Article
  • Authors
  • Metrics
  • Comments
  • Media Coverage
Download PDF
 
  • Citation
  • XML
Print
  • Print article
  • Reprints
Share
  • RedditReddit
  • FacebookFacebook
  • LinkedInLinkedIn
  • MendeleyMendeley
  • PubChasePubChase
  • TwitterTwitter
  • EmailEmail
 
Advertisement

Subject Areas
?

For more information about PLOS Subject Areas, click here.

We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

  • B cells  

    Is the Subject Area "B cells" applicable to this article?

    Thanks for your feedback.

  • Immunologic adjuvants  

    Is the Subject Area "Immunologic adjuvants" applicable to this article?

    Thanks for your feedback.

  • Vaccines  

    Is the Subject Area "Vaccines" applicable to this article?

    Thanks for your feedback.

  • Cytotoxic T cells  

    Is the Subject Area "Cytotoxic T cells" applicable to this article?

    Thanks for your feedback.

  • Toll-like receptors  

    Is the Subject Area "Toll-like receptors" applicable to this article?

    Thanks for your feedback.

  • Antibodies  

    Is the Subject Area "Antibodies" applicable to this article?

    Thanks for your feedback.

  • B cell receptors  

    Is the Subject Area "B cell receptors" applicable to this article?

    Thanks for your feedback.

  • T cells  

    Is the Subject Area "T cells" applicable to this article?

    Thanks for your feedback.

  • Publications
  • PLOS Biology
  • PLOS Medicine
  • PLOS Computational Biology
  • PLOS Genetics
  • PLOS Pathogens
  • PLOS ONE
  • PLOS Neglected Tropical Diseases
  • Home
  • Blogs
  • Collections
  • Give feedback
  • LOCKSS
  • Privacy Policy
  • Terms of Use
  • Advertise
  • Media Inquiries
  • Contact

PLOS is a nonprofit 501(c)(3) corporation, #C2354500, based in San Francisco, California, US

PLOS